Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

US Patent 11944644 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T-cells comprising two different chimeric antigen receptors and uses thereof2024
T-cells comprising two different chimeric antigen receptors and uses thereof2024
T-cells comprising two different chimeric antigen receptors and uses thereof2024
T-cells comprising two different chimeric antigen receptors and uses thereof2024
Methods of culturing t cells and uses of same2024
Methods of culturing t cells and uses of same2024
Methods of culturing t cells and uses of same2024
Redirected, genetically-engineered T regulatory cells and their use in suppressi2022
Immunotherapy using redirected allogeneic cells2017
Immunotherapy using redirected allogeneic cells2017
Anti-inflammatory peptides and use thereof2016
Anti-inflammatory peptides and use thereof2016